206 related articles for article (PubMed ID: 33084222)
1. Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer.
He T; Wildey G; McColl K; Savadelis A; Spainhower K; McColl C; Kresak A; Tan AC; Yang M; Abbas A; Dowlati A
Mol Oncol; 2021 Jan; 15(1):195-209. PubMed ID: 33084222
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells.
Mateen S; Raina K; Jain AK; Agarwal C; Chan D; Agarwal R
Epigenetics; 2012 Oct; 7(10):1161-72. PubMed ID: 22965008
[TBL] [Abstract][Full Text] [Related]
3. Definition of a small core transcriptional circuit regulated by AML1-ETO.
Stengel KR; Ellis JD; Spielman CL; Bomber ML; Hiebert SW
Mol Cell; 2021 Feb; 81(3):530-545.e5. PubMed ID: 33382982
[TBL] [Abstract][Full Text] [Related]
4. Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer.
Coe BP; Thu KL; Aviel-Ronen S; Vucic EA; Gazdar AF; Lam S; Tsao MS; Lam WL
PLoS One; 2013; 8(8):e71670. PubMed ID: 23967231
[TBL] [Abstract][Full Text] [Related]
5. Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets.
Krushkal J; Silvers T; Reinhold WC; Sonkin D; Vural S; Connelly J; Varma S; Meltzer PS; Kunkel M; Rapisarda A; Evans D; Pommier Y; Teicher BA
Clin Epigenetics; 2020 Jun; 12(1):93. PubMed ID: 32586373
[TBL] [Abstract][Full Text] [Related]
6. ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.
Szczepanski AP; Zhao Z; Sosnowski T; Goo YA; Bartom ET; Wang L
Genome Med; 2020 Jul; 12(1):63. PubMed ID: 32669118
[TBL] [Abstract][Full Text] [Related]
7. CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter.
Qiu Z; Zhu W; Meng H; Tong L; Li X; Luo P; Yi L; Zhang X; Guo L; Wei T; Zhang J
Theranostics; 2019; 9(16):4717-4729. PubMed ID: 31367252
[No Abstract] [Full Text] [Related]
8. Correlation between histone acetylation and expression of Notch1 in human lung carcinoma and its possible role in combined small-cell lung carcinoma.
Hassan WA; Takebayashi SI; Abdalla MOA; Fujino K; Kudoh S; Motooka Y; Sato Y; Naito Y; Higaki K; Wakimoto J; Okada S; Nakao M; Ishikawa Y; Ito T
Lab Invest; 2017 Aug; 97(8):913-921. PubMed ID: 28414324
[TBL] [Abstract][Full Text] [Related]
9. Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer.
Yeh KT; Chen TH; Yang HW; Chou JL; Chen LY; Yeh CM; Chen YH; Lin RI; Su HY; Chen GC; Deatherage DE; Huang YW; Yan PS; Lin HJ; Nephew KP; Huang TH; Lai HC; Chan MW
Epigenetics; 2011 Jun; 6(6):727-39. PubMed ID: 21540640
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with
Yun JW; Bae YK; Cho SY; Koo H; Kim HJ; Nam DH; Kim SH; Chun S; Joo KM; Park WY
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959925
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
[TBL] [Abstract][Full Text] [Related]
13. CDKN1A histone acetylation and gene expression relationship in gastric adenocarcinomas.
Wisnieski F; Calcagno DQ; Leal MF; Santos LC; Gigek CO; Chen ES; Demachki S; Artigiani R; Assumpção PP; Lourenço LG; Burbano RR; Smith MC
Clin Exp Med; 2017 Feb; 17(1):121-129. PubMed ID: 26567008
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21
Chatterjee B; Ghosh K; Kanade SR
Biofactors; 2019 Sep; 45(5):818-829. PubMed ID: 31317586
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO.
Berg T; Fliegauf M; Burger J; Staege MS; Liu S; Martinez N; Heidenreich O; Burdach S; Haferlach T; Werner MH; Lübbert M
Haematologica; 2008 Nov; 93(11):1728-33. PubMed ID: 18790797
[TBL] [Abstract][Full Text] [Related]
16. AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer.
Tian Y; Wang G; Hu Q; Xiao X; Chen S
J Cell Biochem; 2018 Apr; 119(4):3706-3715. PubMed ID: 29236325
[TBL] [Abstract][Full Text] [Related]
17. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.
Tanaka N; Toyooka S; Soh J; Kubo T; Yamamoto H; Maki Y; Muraoka T; Shien K; Furukawa M; Ueno T; Asano H; Tsukuda K; Aoe K; Miyoshi S
Lung Cancer; 2012 Apr; 76(1):32-8. PubMed ID: 22047961
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
Hokari S; Tamura Y; Kaneda A; Katsura A; Morikawa M; Murai F; Ehata S; Tsutsumi S; Ishikawa Y; Aburatani H; Kikuchi T; Miyazono K; Koinuma D
Mol Oncol; 2020 Feb; 14(2):277-293. PubMed ID: 31782890
[TBL] [Abstract][Full Text] [Related]
19. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer.
Yazawa T; Sato H; Shimoyamada H; Okudela K; Woo T; Tajiri M; Ogura T; Ogawa N; Suzuki T; Mitsui H; Ishii J; Miyata C; Sakaeda M; Goto K; Kashiwagi K; Masuda M; Takahashi T; Kitamura H
Am J Pathol; 2009 Sep; 175(3):976-87. PubMed ID: 19679880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
